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Lawmakers want to know the returns on their investment.  The difficulties in measuring 
benefits and costs, and attributing some portion of those to specific research and 
technology development (R&D) programs, has meant that many such studies are not seen 
as credible by those lawmakers.  This paper describes a methodology that improves upon 
an already credible approach developed for a 2001 National Research Council study:  
“Energy Research at DOE: Was It worth It?”   Three benefit-cost studies using this 
modified approach will be completed by the U.S. Department of Energy’s Energy 
Efficiency and Renewable Energy in 2009. 
 
The key evaluation questions to be answered in these studies are:  
• To what extent have programs produced “actual” economic benefits (energy-
savings, renewable market growth, and other positive economic effects) relative 
to the next best alternative? 
• To what extent have programs promoted environmental benefits and enhanced 
energy security by providing alternative energy sources and energy efficiency, 
and protecting existing sources?   
• Would today’s commercialized technologies have happened at the same time, 
with the same scope and scale, and with the same extent of deployment without 
DOE involvement? 
• To what extent do benefits attributable to DOE involvement exceed DOE R&D 
expenditures? 
 
The modified methodology will implement the retrospective benefits estimation 
recommendations of the May 2002 EERE Strategic Technical Review and the DOE 
Benefits Workshop held in 2003. 
 
Economic performance metrics that are calculated are Net benefits, Benefit-cost ratio, 
and Internal Rate of Return.  All of these are social & public returns that include private 
returns but these are not calculated separately.  The types of benefits and costs included 
in calculation of metrics are Investment costs, Energy costs, Other operating costs, 
Maintenance, repair, and replacement costs, and Rents or royalty payments.   
 
Benefits and costs for selected technology “winners” are calculated compared against the 
next best alternative. Differences are expressed as year-by-year dollar cash flows, 
adjusted to constant dollars, and amounts are “discounted” for the time value of money 
(apart from inflation) using OMB-specified real discount rate.  Additionally, a “Cluster 
approach” is used that compares benefits of larger elements of a program to investment 
costs of the entire program. The cluster approach describes the larger program and 
government’s role, as well as the specific technology elements.  It generates a minimum 
estimate of return for the program without performing detailed analysis of everything in it, 
thereby increasing feasibility of the analysis. 
 
Environmental and Security benefits are also assessed. Environmental benefits quantified 
will focus on reduction in air pollution.  Security benefits will focus on cumulative fuel 
savings (oil and natural gas), expressed in physical terms. Important benefits that cannot 
be measured quantitatively within the scope of a study are discussed qualitatively.   
 
Knowledge Benefits were added to the NRC framework by experts attending the 2003 
DOE Benefits Conference.  This EERE benefit-cost methodology calls for a more 
comprehensive and quantitative assessment of knowledge benefits of the technologies 
selected for study than have previous benefit-cost studies.  Studies identify and document 
linkages between more than three decades of DOE R&D and, in the 2009 studies, 
commercial renewable power generation.  Studies use interviews with scientists, 
engineers, and administrators in government, as well as manufacturers and their 
customers.  They also review documents and databases for evidence of linkages, and  
apply the tools of patent and publication citation analysis, and publication co-author 
analysis to shed further light on the paths through which outputs of DOE-funded R&D 
have been disseminated to producers and users.   
 
In contrast to the 2001 NRC study, the modified approach requires a case-by-case 
assessment of additionality—the difference that DOE made in the outcome. Rather than 
use a rule of thumb, the EERE modified NRC approach will examine an array of ways 
additionality can occur.  These include acceleration in the development and introduction 
into the market of a technology, change in the scale, performance characteristics, function, 
and cost of a technology (e.g., its emissions profile or its durability), acceleration in the 
rate at which a technology gains share of the existing domestic market after it is initially 
introduced, increase in access of U.S. firms to foreign markets, expansion in the total size 
of domestic and foreign markets, and reduction in the total investment costs (combined 
public and private) of achieving the desired outcome as compared with achieving the 
same with industry going it alone. 
 
To have more comparability across EERE benefit-cost studies, this approach will use 
generic logic models to describe the changes over the time period in technologies and 
markets using a common language.  Activities, external influences, and progress over 
time in R&D will use the stages of the Stage Gate process:  Preliminary investigation, 
detailed investigation, development, validation, and commercial launch.  Activities, 
external influences, and progress over time in the “readiness” of the market and 
technology adoption will use four market domains.  In addition to the usual domain of the 
end user that looks at adoption of a technology, there are three market infrastructure 
domains: Information, Policy/Government, and Business. Examples of activities in these 
infrastructure domains are the Wind Resources database, EERE efforts on new appliance 
standards, and partnerships with industry on solar manufacturing R&D.   
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 This paper proposes an evaluation technique for evaluating the impacts of new 
scientific instruments in a way that avoids the pitfalls of “economic-only” cost-benefit 
analysis and meets the needs of the customer organization and Congress.   On several 
occasions, Congress has rejected the requested appropriation of 700 million dollars to 
place a new suite instruments, the Hyperspectral Sounder (HES), on the GOES T, a new 
weather satellite to be launched in 2016, by the National Oceanographic and Atmospheric 
Agency (NOAA).  Part of the reason for the rejection is that the economic cost-benefit 
analysis completed by NOAA indicates only marginal gains from this investment.  At the 
macro level of predicting the national weather, this is true.  Over the last twenty years 
there has been considerable gain in the accuracy of the sixth and seventh day weather 
predictions.  Of course, you feel quite differently about this at the local or meso (regional 
level) because you focus on the many errors--the unannounced snowstorm that shuts 
down your city for three days, the unexpected tornado that kills people in your state, or 
the sudden rainstorm that drowned your picnic.  The specific strength of this new set of 
instruments is that it can be more specific about where severe weather will occur. 
 Another reason why Congress has been reluctant to move ahead, outside of the 
enormous budget deficits, is the lack of support of the National Weather Service (NWS) 
within NOAA.  Again, there are some understandable reasons for this resistance.  NWS 
uses a global model from which meso models are derived.  In fact, the local weather 
predictions are made by various meteorologists who work for the radio and television 
stations in your community.  The macro models presently push the limits of super 
computers and cannot easily absorb real time data over short periods (say six hours or 
less).  To do so, requires totally reworking the entire set of complex equations used for 
weather prediction involving inputs from around the world.   This is a very expensive and 
time consuming task and it is not clear that there is a large enough computer to handle 
this new information.  This is a classic example of path dependency because of an 
existing technology and cognitive model along with considerable sunk costs in the 
present system. 
 Therefore, our new evaluation techniques have to accomplish three objectives: 
1) Develop new criteria that avoid the pitfalls of the economic cost-benefit analyses 
2) Create a case that would convince Congress despite budget deficits that 
investment in the HES is valuable for their constituents 
3) Propose a political strategy that overcomes the resistance of NWS 
In addition, we want our discussion of these new evaluation techniques to be in terms that 
allow others to apply these ideas to situations other than weather forecasting. 
 As indicted above, the strong point of HES is that it predicts sudden weather 
changes (within six hours) on a meso scale (region or even locality).  It can do this 
because it is measuring the following weather parameters:  vertical moisture profiles, 
vertical temperature profiles, derived stability indices, derived motion of winds, moisture 
flux and ozone total.  Together these measure sudden inversions, the major cause of 
unexpected instabilities of weather associated with tornados, severe winter storms, floods, 
and the like. 
 Therefore, the solution to the first problem is to focus on improvements in 
warning time for each of these severe weather events.  To take one example, to move 
from 13 minutes to 13 hours of warning time for a tornado saves lives.  Note, that 
warning time does not reduce the destruction of property.  This is still there.  But this is 
one reason why economic benefits are largely but not always beside the point and 
especially for extreme weather events.  The damage still exists although it might be 
slightly mitigated but one can save lives.  Besides tornados, thunderstorms including 
flooding, and winter storms, we also want to focus on sudden decreases in air quality and 
its health consequences.   
 The political solution for Congress is to chart every unanticipated severe weather 
event in each congressional district and state during the past year to indicate how many of 
their constituents would be affected by earlier warning times.  Of course, the question is 
what evidence can be marshaled for a system that is not operational, one of the major 
parts of our presentation. 
 The strategy for handling the NWS is to advocate the creation of separate meso 
models, which can be much simpler and adapted to the specific geographical regions of 
the United States and of course constructed to absorb real time data.  In other words, the 
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 As part of the continued efforts of the Center for Innovation to develop new 
evaluation strategies, we developed a new framework and proposed this in an invited 
white paper for a major assessment called for by the Canadian Academy of Health 
Sciences.  What makes this framework new is that is focuses on the treatment sector 
because this is where the greatest variations in both research investments and potential 
returns are concentrated.  By focusing on the treatment process, a very fine-grained 
evaluation is possible, which then can be aggregated to the macro level, the level of 
policy makers.  But since it starts with the treatment process, it can pinpoint where either 
too much money in research has been invested or not enough. This is a very important 
question for policy-makers. 
 One critical component of this framework is that it provides precise definitions of 
what is the treatment process as distinct from the research process, the differences in 
where treatments are provided and where research is conducted, and the distinctions 
between the micro, meso, and macro levels of evaluation.  These definitions are 
important because of the mismatch among them. 
The specific metrics of the framework are:  
1. Metrics of health care impact by stage in the treatment process; 
2. Metrics of research investment by arenas within the production of medical 
knowledge within the specific treatment sector; 
3. Metrics of contributions to scientific knowledge; 
4. Metrics of network gaps in the production of innovative treatment 
protocols; 
5. Metrics of economic and social benefits of medical research. 
 
 The key starting point is the treatment process, which is defined by the differences 
in the nature of the illness, injury or health care problem that is being treated.  The 
metrics for this are groups according to the four stages:  prevention, intake and 
assessment, treatment, and post-treatment including long term care.  Carefully specifying 
the stages in the treatment process associated with a particular morbidity allows for a 
fine-grained set of health care impact metrics or indicators.  One could make additional 
distinctions within these four stages.  For example, one might want to distinguish 
between diagnosis and prognosis. In addition to the four stages of the treatment process, 
we have added a category, knowledge about the health care problem, because a major 
part of biomedical and population research focuses on the development of understanding 
about the health care problem that eventually can lead to either prevention or treatment.  
Two to three indicators are suggested for each stage.   The problem of actual vs. potential 
benefits--an issue that plagues many evaluations--is also discussed. 
 To place the evaluation in its proper context, the kinds of investments made in 
medical research, both human and capital, are classified according to the specific stages 
of the treatment process.  This highlights gaps.  Another set of measures deals with 
detecting gaps in the idea innovation network (Hage and Hollingsworth, 2000) associated 
with a specific treatment sector.  This is particularly important given the presence of a 
valley of death between medical research and the development of industrial innovations 
perceived to exist, again illustrating the advantages of selecting the sector level in the 
health care delivery system. 
 A special section on metrics for knowledge contributions is suggested as well, 
given the importance of this for most academics.  In this, a special emphasis is placed on 
the international impact of these contributions.   
 Metrics for economic benefits flow naturally from the specific indicators for each 
stages of the treatment process.  Examples include value of illness days saved from 
decline in morbidity incidence, reduction in the costs of tests for diagnosis, reduction in 
the patient’s costs of waiting, value of days saved in hospitalization, value of days saved 
in rehabilitation and after care, etc. Surprisingly, focusing on the stages in the treatment 
process, which would seem to involve more work, simplifies the task of specifying the 
specific benefits of a particular kind of research finding.   Finally a number of societal 
benefits are indicated as well including such things as increased equality in health care 
and duration of life by class and gender. 
 
 
 
